Natural killer-dendritic cell cross-talk in cancer immunotherapy

Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate

Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia

Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial

Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

Natural-killer cells and dendritic cells: „l’union fait la force“

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial

Chaperone-rich cell lysates, immune activation and tumor vaccination

Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function